Professional Bio
Melinda Aldrich, PhD, MPH, is a Professor in the Division of Genetic Medicine and Clinical Pharmacology within the Department of Medicine at Vanderbilt University Medical Center. Her research has two central area of focus: (1) understand genetic and non-genetic factors contributing to lung cancer and (2) address lung cancer screening access.
Dr. Aldrich's lab collaborates with large-scale population-based cohorts such as the Southern Community Cohort Study, the Multiethnic Cohort, the Black Women's Health Study, biobanks linked to electronic health records, such as the Vanderbilt DNA biobank, BioVU, as well as international consortia such as the International Lung Cancer Consortium and LC3. The Aldrich Lab is also collaborating with national colleagues to investigate the genetics of immunotherapy treatment among lung cancer patients.
Dr. Aldrich leads community-engaged dissemination strategies to build awareness around the importance of early detection of lung cancer. Her research has been used in key guidelines for lung cancer screening from the U.S. Preventive Services Task Force.
Relevant Links
Publications
Education
MPH - University of California, Berkeley, 2003
PhD - Epidemiology - University of California, Berkeley, 2007
Fellowship - Genetic Epidemiology - University of California, Berkeley, 2010
Contact
Email
Kimryn.Rathmell@Vumc.Org
Address
777 Preston Research Building
2220 Pierce Ave
Nashville, TN 37232-6307